source
- Podcast explores the limits of "blue zones" concept in aging researchOn a recent First Opinion podcast, medical journalist Shelley Wood and cardiologist Eric Topol discussed the "blue zones" concept and its relevance to aging research. They traced the idea back to…
- FDA approves vepdegestrant for ESR1-mutated ER-positive advanced breast cancerOn May 1, 2026 the FDA gave its first approval to vepdegestrant, an oral selective estrogen receptor degrader, for adult patients with estrogen receptor-positive, HER2-negative breast cancer that c…